Project Number 5R21NS117982-02 Agency/Funding Organization NINDS Funding Year 2021 View Full Project Details for Development of immunotherapy targeting pathological TDP-43 in ALS and FTLD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies b. TDP-43 and FUS Researcher and Organization Principal Investigator POLYMENIDOU, MAGDALINI Principal Investigator First Name MAGDALINI Principal Investigator Last Name POLYMENIDOU Awardee Organization UNIVERSITY OF ZURICH Contact PI Country Switzerland Project Detail Funding Opportunity Announcement PA-18-358: NINDS Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) FY Overall Cost $101,101 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GUBITZ, AMELIE
